Your session is about to expire
← Back to Search
Imaging Techniques for Intracranial Hemorrhage (SPINNERS Trial)
N/A
Recruiting
Led By Marios-Nikos Psychogios, Prof Dr
Research Sponsored by University Hospital, Basel, Switzerland
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patient presenting within 24 hours of last seen well
Age above 18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 0 - within 4 hours of enrollment
Awards & highlights
Summary
This trial aims to determine if a specific type of imaging, called non-contrast syngo DynaCT Sine Spin, is as effective as another type of imaging, called non-contrast MDCT
Who is the study for?
This trial is for adults over 18 with symptoms of a stroke, who can give informed consent and arrive at the hospital within 24 hours of their last known well time. They should be able to have two types of head scans within four hours. It's not suitable for those who don't meet these timing or consent requirements.Check my eligibility
What is being tested?
The study tests if a new type of non-contrast head scan called syngo DynaCT Sine Spin is as good as the standard non-contrast MDCT scan in detecting bleeding inside the skull after a stroke.See study design
What are the potential side effects?
Since both interventions are diagnostic imaging techniques rather than medications, they do not have typical side effects like drugs do. However, there may be risks associated with exposure to radiation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I sought medical help within 24 hours of feeling unwell.
Select...
I am older than 18 years.
Select...
I have had a stroke with significant symptoms and received specific scans within 4 hours.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 0 - within 4 hours of enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 0 - within 4 hours of enrollment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Occurrence of an intracranial hemorrhage (yes/no)
Other outcome measures
Change in Adverse Device Events (ADEs)
Trial Design
1Treatment groups
Experimental Treatment
Group I: Cranial non-contrast syngo DynaCT Sine Spin scanExperimental Treatment2 Interventions
There is only one arm as all patients undergo the same intervention. Subjects with clinical features/symptoms of a stroke (hemorrhagic and non-hemorrhagic stroke patients) will be enrolled. All patients will undergo first a non-contrast MDCT scan and then a non-contrast syngo DynaCT Sine Spin head scan within a maximum timespan of 4 hours between both scans. Only patients in which no invasive procedure in between is planned can be enrolled.
Find a Location
Who is running the clinical trial?
University Hospital, Basel, SwitzerlandLead Sponsor
980 Previous Clinical Trials
1,971,204 Total Patients Enrolled
17 Trials studying Stroke
10,296 Patients Enrolled for Stroke
Siemens Healthineers AGUNKNOWN
2 Previous Clinical Trials
2,278 Total Patients Enrolled
1 Trials studying Stroke
50 Patients Enrolled for Stroke
Adam S Arthur, MD, MPHStudy ChairSemmes Murphey Clinic and University of Tennessee Health Sciences Center
Share this study with friends
Copy Link
Messenger